Position/s

Director of Endocrinology
Medicine/General

Biography

director of endocrinology at flinders medical centre with a conjoint position as professor of medicine at flinders university, nikolai petrovsky is also vice-president and secretary-general of the international immunomics society. active in diabetes, endocrinology and vaccine research, he is the founder of vaxine, a company funded by the us national institutes of health to develop novel vaccine technologies. in 2009 vaxine won the amp innovation award at the telstra business awards and australia's coolest company award from australian anthill magazine. nikolai petrovsky has developed vaccines against influenza, hepatitis b, sting allergy, malaria, japanese encephalitis, rabies and hiv, has authored over 90 papers and chapters and is a regular invited speaker at international vaccine conferences.

Qualifications

  • Bachelor of Medical Science (University of Tasmania), 1979
  • Bachelor of Medicine, Bachelor of Surgery (MBBS), University of Tasmania, 1982
  • Fellowship, Australian Institute of Company Directors (FAICD) 1990
  • Fellowship, Royal Australasian College of Physicians (FRACP) 1994
  • PhD, University of Melbourne, 1998
  • Graduate Certificate in Education Studies, University of Sydney, 2002

Honours, awards and grants

  • NH&MRC Postgraduate Medical Research Scholarship, 1994
  • Cleveland Young Investigator Award, Royal Melbourne Hospital, 1995
  • Edith Moffat Award, Walter and Eliza Hall Institute, 1996
  • Distinguished Speaker Award, International Immunomics Society, 2005
  • Flinders University Public Affairs and Alumni Media Award 2005 & 2007
  • AMP  Innovation Award, 2009 Telstra Business Award
  • AusIndustry Innovation Award, Australian Anthill Company Awards

Key responsibilities

Director of the Department of Diabetes and Endocrinology at Flinders Medical Centre. Actively involved in medical research, supervision of postgraduate research students and teaching of medical curriculum at Flinders University

Teaching interests

Diabetes Mellitus
Vaccine development
Biotechnology

Research interests

  • Pathogenesis of type 1 diabetes
  • Obesity and type 2 diabetes
  • Vaccine development
  • Immuno-informatics

Publications

  • Sajkov, D., Mupunga, B., Bowden, J. and Petrovsky, N. (2013). Pulmonary Hypertension in Chronic Lung Diseases and/or Hypoxia. In JM Elwing & RJ Panos, ed. Pulmonary Hypertension. Rijeka, Croatia: InTech, pp. 21-45.
    [10.5772/55681]
  • Sajkov, D., Latimer, K. and Petrovsky, N. (2011). Dyspnea in Pulmonary Arterial Hypertension. In Roxana Sulica & Ioana Preston, ed. Pulmonary Hypertension - From Bench Research to Clinical Challenges. 10.5772/1291: InTech, pp. 191-208.
    [10.5772/26836]
  • Petrovsky, N. (2009). Pharmacological Management of Endocrine Conditions in the Elderly Patient. In Stephen Jackson, Paul Jansen, Arduino Mangoni, ed. Prescribing for Elderly Patients. N/A: Wiley, pp. 391-401.
    [10.1002/9780470017975.ch36]
  • Gordon, D.L., Petrovsky, N., Sadlon, T., Tan, S.D., Honda-Okubo, Y., Phillips, P., et al. (2010). Pattern of serological responses following novel H1N1 2009 Influenza A infection in adults. In Proceedings of Annual Scientific Meeting Australian Society for Microbiology. AustraliaAnnual Scientific Meeting Australian Society for Microbiology. Sydney. Jul 2010, pp. 104-104.
  • Gordon, D.L., Honda-Okubo, Y., Sajkov, D., Woodman, R.J., Petrovsky, N., Heinzel, S., et al. (2010). Immunogenicity and safety of a unique Influenza A (2009 H1N1) vaccine combining recombinant hemagglutinin with a novel polysaccharide adjuvant. In Proceedings of Annual Scientific Meeting Australian Society for Microbiology. The Australian Society for Microbiology Annual Scientific Meeting. Sydney. Jul 2010, pp. 56-56.
  • Cristillo, A., Ferrari, M., Hudacik, L., Thompson, D., Bowen, B., Lewis, B., et al. (2009). Induction of persistent mucosal humoral and cellular responses following immunization of mice with HIV-1 envelope protein in inulin-derived adjuvants. In Retrovirology. AIDS Vaccine 2009. Paris, France. Oct 2009, pp. P166.
    [10.1186/1742-4690-6-S3-P166]
  • Abhary, S., Burdon, K.P., Gupta, A., Petrovsky, N. and Craig, J. (2008). Common sequence variation in the VEGF gene predicts risk of diabetic retinopathy. In Charles N J McGhee, Victoria Cartwright (Managing Editor), ed. Clinical and Experimental Ophthalmology. Australia: Wiley-Blackwell Publishing Asia. RANZCO 40th Annual Scientific Congress. Melbourne. Nov 2008, pp. A722-A723.
    [10.1111/j.1442-9071.2008.01850.x]
  • He, Y., Cao, Z., De Groot, A., Brusic, V., Schönbach, C. and Petrovsky, N. (2013). Computational vaccinology and the ICoVax 2012 workshop. BMC Bioinformatics, 14(Suppl 4) pp. I1.
    [10.1186/1471-2105-14-S4-I1]
  • Petrovsky, N. (2013). Vaccine adjuvant safety: the elephant in the room. Expert Review of Vaccines, 12(7) pp. 715-717.
    [10.1586/14760584.2013.811198]
  • Petrovsky, N. (2013). Unconventional Vaccines: Progress and Challenges. Journal of Vaccines and Vaccination, 4(4) pp. 1-4.
  • Petrovsky, N. (2013). Vaccine adjuvants: in search of new paradigms. Expert Review of Vaccines, 12(7) pp. 723-726.
    [10.1586/14760584.2013.811197]
  • Barclay, T.G., Ginic-Markovic, M., Cooper, P.D. and Petrovsky, N. (2012). The chemistry and sources of fructose and their effect on its utility and health implications. Journal of Excipients and Food Chemicals, 3(2) pp. 67-82.
    [Web Link]
  • Spero, D., Petrovsky, N. and De Groot, A. (2012). Report from the field: Fifth Vaccine Renaissance in Providence RI. Human Vaccines & Immunotherapeutics, 8(7) pp. 1006-1009.
    [10.4161/hv.19779]
  • Petrovsky, N. (2011). Immunome Research - Five Years On. Immunome Research, 7(1) pp. 1-4.
  • Petrovsky, N. (2011). The vaccine renaissance. Human Vaccines, 7(2) pp. 149-152.
    [10.4161/hv.7.2.14321]
  • Petrovsky, N. and Ross, T. (2011). Challenges in improving influenza vaccine protection in the elderly. Expert Review of Vaccines, 10(1) pp. 715-11.
    [10.1586/erv.10.153]
  • Petrovsky, N. and Sajkov, D. (2011). Pediatric influenza immunization. Expert Review of Vaccines, 10(5) pp. 567-570.
    [10.1586/erv.11.53]
  • Petrovsky, N. (2010). Lessons learned from the H1N1 2009 pandemic. Human Vaccines, 6(10) pp. 780-783.
    [10.4161/hv.6.10.12981]
  • Petrovsky, N. (2009). Focus on Influenza vaccines. Human Vaccines, 5(10) pp. 658-659.
    [10.4161/hv.5.10.9315]
  • Petrovsky, N. (2008). The vaccines development forum. IDrugs, 11(7) pp. 478-481.
  • Petrovsky, N. (2008). The vaccines development forum. IDrugs, 11(7) pp. 478-481.
    [Scopus]
  • Cooper, P., Barclay, T., Ginic-Markovic, M. and Petrovsky, N. (2014). Gamma ray sterilization of delta inulin adjuvant particles (Advaxâ„¢) makes minor, partly reversible structural changes without affecting adjuvant activity. Vaccine, 32(5) pp. 552-557.
    [10.1016/j.vaccine.2013.11.105]
  • Cooper, P., Barclay, T., Ginic-Markovic, M., Gerson, A. and Petrovsky, N. (2014). Inulin isoforms differ by repeated additions of one crystal unit cell. CARBOHYDRATE POLYMERS, 103 pp. 392-397.
    [10.1016/j.carbpol.2013.12.066]
  • Saade, F., Honda-Okubo, Y., Trec, S. and Petrovsky, N. (2013). A novel hepatitis B vaccine containing Advax™, a polysaccharide adjuvant derived from delta inulin, induces robust humoral and cellular immunity with minimal reactogenicity in preclinical testing. Vaccine, 31(15) pp. 1999-2007.
    [10.1016/j.vaccine.2012.12.077]
  • Petrovsky, N., Larena, M., Siddharthan, V., Prow, N., Hall, R., Lobigs, M., et al. (2013). An Inactivated Cell Culture Japanese Encephalitis Vaccine (JE-ADVAX) Formulated with Delta Inulin Adjuvant Provides Robust Heterologous Protection against West Nile Encephalitis via Cross-Protective Memory B Cells and Neutralizing Antibody. Journal of Virology, 87(18) pp. 10324-10333.
    [10.1128/JVI.00480-13]
  • Petrovsky, N., Honda-Okubo, Y., Royals, M., Bragg, K. and Sajkov, D. (2013). A randomized controlled study to assess the immunogenicity and tolerability of a 2012 trivalent seasonal inactivated influenza vaccine administered via a disposable syringe jet injector device versus a traditional pre-filled syringe and needle. Trials in Vaccinology, 2 pp. 39-44.
    [10.1016/j.trivac.2013.09.002]
  • Larena, M., Prow, N., Hall, R., Petrovsky, N. and Lobigs, M. (2013). JE-ADVAX vaccine protection against Japanese encephalitis virus mediated by memory B cells in the absence of CD8(+) T cells and pre-exposure neutralizing antibody. Journal of Virology, 87(8) pp. 4395-4402.
    [10.1128/JVI.03144-12]
  • Kaidonis, G., Abhary, S., Daniell, M., Gillies, M., Fogarty, R., Petrovsky, N., et al. (2013). Genetic study of diabetic retinopathy: recruitment methodology and analysis of baseline characteristics. Clinical and Experimental Ophthalmology,
    [10.1111/ceo.12239]
  • Cooper, P., Barclay, T., Ginic-Markovic, M. and Petrovsky, N. (2013). The polysaccharide inulin is characterized by an extensive series of periodic isoforms with varying biological actions. Glycobiology, 23(10) pp. 1164-1174.
    [10.1093/glycob/cwt053]
  • Barclay, T., Constantopoulos, K., Zhang, W., Fujiki, M., Petrovsky, N. and Matisons, J. (2013). Chiral Self-Assembly of Designated Amphiphiles: Influences on Aggregate Morphology. Langmuir, 29(32) pp. 10001-10010.
    [10.1021/la401987y]
  • Marion, V., Mockel, A., De Melo, C., Obringer, C., Claussmann, A., Simon, A., et al. (2012). BBS-induced ciliary defect enhances adipogenesis, causing paradoxical higher-insulin sensitivity, glucose usage, and decreased inflammatory response . Cell Metabolism, 16(3) pp. 363-377.
    [10.1016/j.cmet.2012.08.005]
  • Li, L., Saade, F. and Petrovsky, N. (2012). The future of human DNA vaccines. Journal of Biotechnology, 162(2) pp. 171-182.
    [10.1016/j.jbiotec.2012.08.012]
  • Honda-Okubo, Y., Saade, F. and Petrovsky, N. (2012). Advax™, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses. Vaccine, 30(36) pp. 5373-5381.
    [10.1016/j.vaccine.2012.06.021]
  • Gordon, D., Sajkov, D., Woodman, R., Honda-Okubo, Y., Cox, M.M.J., Heinzel, S., et al. (2012). Randomized clinical trial of immunogenicity and safety of recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvant. Vaccine, 30(36) pp. 5407-5416.
    [10.1016/j.vaccine.2012.06.009] [Scopus]
  • Fogarty, R., Abhary, S., Javadiyan, S., Kasmeridis, N., Petrovsky, N., Whiting, M., et al. (2012). Relationship between DDAH gene variants and serum ADMA level in individuals with type 1 diabetes. Journal of Diabetes and Its Complications, 26(3) pp. 195-198.
    [10.1016/j.jdiacomp.2012.03.022] [Scopus]
  • Barclay, T.G., Ginic-Markovic, M., Johnston, M., Cooper, P. and Petrovsky, N. (2012). Observation of the keto tautomer of D-fructose in D2O using 1H NMR spectroscopy. Carbohydrate Research, 347(1) pp. 136-141.
    [10.1016/j.carres.2011.11.003] [Scopus]
  • Barclay, T.G., Ginic-Markovic, M., Johnston, M., Cooper, P. and Petrovsky, N. (2012). Analysis of the hydrolysis of inulin using real time 1H NMR spectroscopy. Carbohydrate Research, 352 pp. 117-125.
    [10.1016/j.carres.2012.03.001] [Scopus]
  • Saade, F. and Petrovsky, N. (2012). Technologies for enhanced efficacy of DNA vaccines. Expert Review of Vaccines, 11(2) pp. 189-209.
    [10.1586/erv.11.188]
  • Saade, F., Gorski, S.A. and Petrovsky, N. (2012). Pushing the frontiers of T-cell vaccines: Accurate measurement of human T-cell responses. Expert Review of Vaccines, 11(12) pp. 1459-1470.
    [10.1586/erv.12.125]
  • Colby Layton, R., Petrovsky, N., Gigliotti, A.P., Pollock, Z., Knight, J., Donart, N., et al. (2011). Delta inulin polysaccharide adjuvant enhances the ability of split-virion H5N1 vaccine to protect against lethal challenge in ferrets. Vaccine, 29(37) pp. 6242-6251.
    [10.1016/j.vaccine.2011.06.078] [Scopus]
  • Cooper, P. and Petrovsky, N. (2011). Delta inulin: A novel, immunologically active, stable packing structure comprising ß-D-[2 ? 1] poly(fructo-furanosyl) ad-glucose polymers . Glycobiology, 21(5) pp. 595-606.
    [10.1093/glycob/cwq201] [Scopus]
  • Cristillo, A., Ferrari, M., Hudacik, L., Lewis, B., Galmin, L., Bowen, B., et al. (2011). Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations. Journal of General Virology, 92(Pt 1) pp. 128-140.
    [10.1099/vir.0.023242-0]
  • Eckersley, A., Petrovsky, N., Kinne, J., Wernery, R. and Wernery, U. (2011). Improving the dromedary antibody response: The hunt for the ideal camel adjuvant. JOURNAL OF CAMEL PRACTICE AND RESEARCH, 18(1) pp. 30-46.
    [Web Link]
  • Girard, D. and Petrovsky, N. (2011). Alström syndrome: insights into the pathogenesis of metabolic disorders. Nature Reviews Endocrinology, 7 pp. 77-88.
    [10.1038/nrendo.2010.210] [Scopus]
  • Petrovsky, N. and Cooper, P. (2011). Carbohydrate-based immune adjuvants. Expert Review of Vaccines, 10(4) pp. 523-537.
    [10.1586/erv.11.30]
  • Tan, S., Gordon, D., Honda-Okubo, Y., Petrovsky, N., Phillips, P., Huddleston, S., et al. (2011). Serological responses following influenza A H1N1 2009 infection in adults. Journal of Infection, 62(5) pp. 388-393.
    [10.1016/j.jinf.2011.03.002] [Scopus]
  • Abhary, S., Burdon, K.P., Casson, R.J., Goggin, M., Petrovsky, N. and Craig, J. (2010). Association between erythropoietin gene polymorphisms and diabetic retinopathy. Archives of Ophthalmology, 128(1) pp. 102-106.
    [10.1001/archophthalmol.2009.355] [Scopus] [Web Link]
  • Abhary, S., Burdon, K.P., Kuot, A., Javadiyan, S., Whiting, M.J., Kasmeridis, N., et al. (2010). Sequence variation in DDAH1 and DDAH2 genes is strongly and additively associated with serum ADMA concentrations in individuals with type 2 diabetes. PLoS One, 5(3) pp. e9462.
    [10.1371/journal.pone.0009462] [10.1371/journal.pone.0009462] [Scopus]
  • Abhary, S., Burdon, K.P., Laurie, K., Thorpe, S., Landers, J.A., Goold, L., et al. (2010). Aldose reductase gene polymorphisms and diabetic retinopathy susceptibility. Diabetes Care, 33(8) pp. 1834-1836.
    [10.2337/dc09-1893] [10.2337/dc09-1893] [Scopus]
  • Barclay, T.G., Ginic-Markovic, M., Cooper, P. and Petrovsky, N. (2010). Inulin - a versatile polysaccharide with multiple pharmaceutical and food chemical uses. Journal of Excipients and Food Chemicals, 1(3) pp. 27-50.
    [Web Link] [Web Link]
  • Lobigs, M., Pavy, M., Hall, R.A., Lobigs, P., Cooper, P., Kumiya, T., et al. (2010). An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses. Journal of General Virology, 91 pp. 1407-1417.
    [10.1099/vir.0.019190-0] [10.1099/vir.0.019190-0] [Scopus]
  • Petrovsky, N. (2010). Immunomodulation with microbial vaccines to prevent type 1 diabetes mellitus. Nature Reviews Endocrinology, 6 pp. 131-138.
    [10.1038/nrendo.2009.273]
  • Sajkov, D., Petrovsky, N. and Palange, P. (2010). Management of dyspnea in advanced pulmonary arterial hypertension. Current Opinion in Supportive and Palliative Care, 4(2) pp. 76-84.
    [10.1097/SPC.0b013e328338c1e0] [Scopus]
  • Abhary, S., Burdon, K.P., Gupta, A., Lake, S., Selva, D., Petrovsky, N., et al. (2009). Common sequence variation in the VEGFA gene predicts risk of diabetic retinopathy. Investigative Ophthalmology and Visual Science, 50(12) pp. 5552-5558.
    [10.1167/iovs.09-3694] [10.1167/iovs.09-3694] [Scopus]
  • Bracho, G., Zayas, C., Wang, L., Coppel, R., Pérez, O. and Petrovsky, N. (2009). AFCo1, a meningococcal B-derived cochleate adjuvant, strongly enhances antibody and T-cell immunity against Plasmodium falciparum merozoite surface protein 4 and 5. Malaria Journal, 8(1) pp. 1-35.
    [10.1186/1475-2875-8-35] [10.1186/1475-2875-8-35] [Scopus]
  • Abhary, S., Kasmeridis, N., Burdon, K.P., Kuot, A., Whiting, M.J., Yew, W.P., et al. (2009). Diabetic retinopathy is associated with elevated serum asymmetric and symmetric dimethylarginines. Diabetes Care, 32(11) pp. 2084-2086.
    [10.2337/dc09-0816] [10.2337/dc09-0816] [Scopus]
  • Abhary, S., Burdon, K.P., Gupta, A., Petrovsky, N. and Craig, J. (2009). Diabetic retinopathy is not associated with carbonic anhydrase gene polymorphisms. Molecular Vision, 15 pp. 1179-1184.
    [Scopus] [Web Link]
  • Yamamoto, K., Ninomiya, Y., Iseki, M., Nakachi, Y., Kanesaki-Yatsuka, Y., Yamanoue, Y., et al. (2008). 4-Hydroxydocosahexaenoic acid, a potent peroxisome proliferator-activated receptor gamma agonist alleviates the symptoms of DSS-induced colitis. Biochemical and Biophysical Research Communications, 367(3) pp. 566-572.
    [10.1016/j.bbrc.2007.12.188] [10.1016/j.bbrc.2007.12.188] [Scopus]
  • Petrovsky, N. (2008). Freeing vaccine adjuvants from dangerous immunological dogma. Expert Review of Vaccines, 7(1) pp. 7-10.
    [10.1586/14760584.7.1.7] [10.1586/14760584.7.1.7] [Scopus]
  • Petrovsky, N., Heinzel, S., Honda, Y. and Lyons, A.B. (2007). New-age vaccine adjuvants: friend or foe? Biopharm International, 20(suppl8) pp. A24-A33.
    [Scopus]
  • Petrovsky, N. (2006). Novel human polysaccharide adjuvants with dual Th1 and Th2 potentiating activity. Vaccine, 24(Supp 2) pp. s2/26-s2/29.
    [10.1016/j.vaccine.2005.01.107] [10.1016/j.vaccine.2005.01.107] [Scopus]
  • Arsov, T., Silva, D., O'Bryan, M.K., Sainsbury, A., Lee, N.J., Kennedy, C., et al. (2006). Fat Aussie - a new Alstrom syndrome mouse showing a critical role for ALMS1 in obesity, diabetes, and spermatogenesis. Molecular Endocrinology, 20(7) pp. 1610-1622.
    [10.1210/me.2005-0494] [10.1210/me.2005-0494] [Scopus]
  • Arsov, T., Larter, C.Z., Nolan, C.J., Petrovsky, N., Goodnow, C.C., Teoh, N.C., et al. (2006). Adaptive failure to high-fat diet characterizes steatohepatitis in Alms1 mutant mice. Biochemical and Biophysical Research Communications, 342(4) pp. 1152-1159.
    [10.1016/j.bbrc.2006.02.032] [10.1016/j.bbrc.2006.02.032] [Scopus]
  • Petrovsky, N. and Brusic, V. (2006). Bioinformatics for study of autoimmunity. Autoimmunity, 39(8) pp. 635-643.
    [10.1080/08916930601062437] [10.1080/08916930601062437] [Scopus]
  • Socha, L.A., Gowardman, J., Silva, D., Correcha, M. and Petrovsky, N. (2006). Elevation in interleukin 13 levels in patients diagnosed with systemic inflammatory response syndrome. Intensive Care Medicine, 32(2) pp. 244-250.
    [10.1007/s00134-005-0020-6] [10.1007/s00134-005-0020-6] [Scopus]
  • Rajapakse, M., Zhang, G.L., Srinivasan, K.N., Schmidt, B., Petrovsky, N. and Brusic, V. (2006). PREDNOD, a prediction server for peptide binding to the H-2g7 haplotype of the non-obese diabetic mouse. Autoimmunity, 39(8) pp. 645-650.
    [10.1080/08916930601062494] [10.1080/08916930601062494] [Scopus]
  • Cooper, P., Barclay, T., Ginic-Markovic, M., Gerson, A. and Petrovsky, N. (2014). Inulin isoforms differ by repeated additions of one crystal unit cell. CARBOHYDRATE POLYMERS, 103 pp. 392-397.
    [10.1016/j.carbpol.2013.12.066]
  • Cooper, P., Barclay, T., Ginic-Markovic, M. and Petrovsky, N. (2014). Gamma ray sterilization of delta inulin adjuvant particles (Advaxâ„¢) makes minor, partly reversible structural changes without affecting adjuvant activity. Vaccine, 32(5) pp. 552-557.
    [10.1016/j.vaccine.2013.11.105]
  • Saade, F., Honda-Okubo, Y., Trec, S. and Petrovsky, N. (2013). A novel hepatitis B vaccine containing Advax™, a polysaccharide adjuvant derived from delta inulin, induces robust humoral and cellular immunity with minimal reactogenicity in preclinical testing. Vaccine, 31(15) pp. 1999-2007.
    [10.1016/j.vaccine.2012.12.077]
  • Petrovsky, N., Larena, M., Siddharthan, V., Prow, N., Hall, R., Lobigs, M., et al. (2013). An Inactivated Cell Culture Japanese Encephalitis Vaccine (JE-ADVAX) Formulated with Delta Inulin Adjuvant Provides Robust Heterologous Protection against West Nile Encephalitis via Cross-Protective Memory B Cells and Neutralizing Antibody. Journal of Virology, 87(18) pp. 10324-10333.
    [10.1128/JVI.00480-13]
  • Kaidonis, G., Abhary, S., Daniell, M., Gillies, M., Fogarty, R., Petrovsky, N., et al. (2013). Genetic study of diabetic retinopathy: recruitment methodology and analysis of baseline characteristics. Clinical and Experimental Ophthalmology,
    [10.1111/ceo.12239]
  • Cooper, P., Barclay, T., Ginic-Markovic, M. and Petrovsky, N. (2013). The polysaccharide inulin is characterized by an extensive series of periodic isoforms with varying biological actions. Glycobiology, 23(10) pp. 1164-1174.
    [10.1093/glycob/cwt053]
  • Petrovsky, N., Honda-Okubo, Y., Royals, M., Bragg, K. and Sajkov, D. (2013). A randomized controlled study to assess the immunogenicity and tolerability of a 2012 trivalent seasonal inactivated influenza vaccine administered via a disposable syringe jet injector device versus a traditional pre-filled syringe and needle. Trials in Vaccinology, 2 pp. 39-44.
    [10.1016/j.trivac.2013.09.002]
  • Sajkov, D., Mupunga, B., Bowden, J. and Petrovsky, N. (2013). Pulmonary Hypertension in Chronic Lung Diseases and/or Hypoxia. In JM Elwing & RJ Panos, ed. Pulmonary Hypertension. Rijeka, Croatia: InTech, pp. 21-45.
    [10.5772/55681]
  • Sajkov, D., Latimer, K. and Petrovsky, N. (2011). Dyspnea in Pulmonary Arterial Hypertension. In Roxana Sulica & Ioana Preston, ed. Pulmonary Hypertension - From Bench Research to Clinical Challenges. 10.5772/1291: InTech, pp. 191-208.
    [10.5772/26836]
  • Petrovsky, N. (2009). Pharmacological Management of Endocrine Conditions in the Elderly Patient. In Stephen Jackson, Paul Jansen, Arduino Mangoni, ed. Prescribing for Elderly Patients. N/A: Wiley, pp. 391-401.
    [10.1002/9780470017975.ch36]

Expertise for media contact

Interests

  • Vaccine development Expert in development and use of vaccines against diseases including rabies, malaria, hepatitis B, Japanese encephalitis, HIV, Ebola virus etc
  • Influenza Expert in development and use influenza vaccines
  • Diabetes mellitus

Contact

Add to address book
Phone: +61 8 82044572
Email:
Location: School of Medicine (-)
Postal address: GPO Box 2100, Adelaide 5001, South Australia
MACO login

inspiring achievement